Yonistib

Yonistib (Bicalutamide) is an oral antiandrogen medication used primarily in prostate cancer management. This non-steroidal therapy blocks androgen receptors to support treatment goals. Suitable for patients requiring androgen deprivation. Short-term and long-term options available.

Yonistib (Bicalutamide) is used to treat prostate cancer by blocking the effects of androgens, male hormones that can promote cancer growth. It is often prescribed alongside other therapies or as monotherapy depending on clinical needs. Patients may ask, what is Yonistib used for, and the answer includes advanced prostate cancer management and symptom control.

Yonistib may cause mild to moderate effects such as hot flashes, breast tenderness, or upset stomach. Some users report fatigue or mild dizziness. These effects vary by individual and are generally temporary. Regular monitoring is advised to assess tolerance and response.

Store Yonistib at room temperature away from moisture and heat. Keep out of reach of children and pets. Inform your healthcare provider about all medications and supplements you are taking. Avoid crushing or splitting tablets unless directed by a medical professional.

Yonistib may interact with blood thinners, certain antidepressants, and CYP3A4 inhibitors. Alcohol and grapefruit products may alter effectiveness or side effects. Always consult a healthcare provider before combining with other drugs. This list is not exhaustive.